Carregant...
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/188881
Effect of sarcopenia on survival of patients with cirrhosis: A meta-analysis
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
The association between sarcopenia and prognosis in patients with cirrhosis remains to be determined. In this study, we aimed to quantify the association between sarcopenia and the risk of mortality in patients with cirrhosis, by sex, underlying liver disease etiology, and severity of hepatic dysfunction.PubMed, Web of Science, EMBASE, and major scientific conference sessions were searched without language restriction through 13 January 2021 with additional manual search of bibliographies of relevant articles. Cohort studies of ?100 patients with cirrhosis and ?12 months of follow-up that evaluated the association between sarcopenia, muscle mass and the risk of mortality were included.22 studies with 6965 patients with cirrhosis were included. The pooled prevalence of sarcopenia in patients with cirrhosis was 37.5% overall (95% CI 32.4%-42.8%), higher in male patients, patients with alcohol associated liver disease (ALD), patients with CTP grade C, and when sarcopenia was defined in patients by lumbar 3- skeletal muscle index (L3-SMI). Sarcopenia was associated with the increased risk of mortality in patients with cirrhosis (adjusted-hazard ratio [aHR] 2.30, 95% CI 2.01-2.63), with similar findings in sensitivity analysis of cirrhosis patients without HCC (aHR 2.35, 95% CI 1.95-2.83) and in subgroup analysis by sex, liver disease etiology, and severity of hepatic dysfunction. The association between quantitative muscle mass index and mortality further supports the poor prognosis for patients with sarcopenia (aHR 0.95, 95% CI 0.93-0.98). There was no significant heterogeneity in all analyses.Sarcopenia was highly and independently associated with higher risk of mortality in patients with cirrhosis.The prevalence of sarcopenia and its association with death in patients with cirrhosis remain unclear. This meta-analysis indicated that sarcopenia affected about one-third of patients with cirrhosis and up to 50% in patients with ALD or Child's class C cirrhosis. Sarcopenia was independently associated with about 2-fold higher risk of mortality in patients with cirrhosis. The mortality rate increased with greater severity or longer period of having sarcopenia. Increasing awareness about the importance of sarcopenia in patients with cirrhosis among stakeholders must be prioritized.
Matèries
Matèries (anglès)
Citació
Citació
TANTAI, Xinxing, LIU, Yi, YEO, Yee hui, PRAKTIKNJO, Michael, MAURO, Ezequiel, HAMAGUCHI, Yuhei, ENGELMANN, Cornelius, ZHANG, Peng, JEONG, Jae yoon, VAN VUGT, Jeroen laurens ad, XIAO, Huijuan, DENG, Huan, GAO, Xu, YE, Qing, ZHANG, Jiayuan, YANG, Longbao, CAI, Yaqin, LIU, Yixin, LIU, Na, LI, Zongfang, HAN, Tao, KAIDO, Toshimi, SOHN, Joo hyun, STRASSBURG, Christian, BERG, Thomas, TREBICKA, Jonel, HSU, Yao chun, IJZERMANS, Jan nicolaas maria, WANG, Jinhai, SU, Grace l., JI, Fanpu, NGUYEN, Mindie h.. Effect of sarcopenia on survival of patients with cirrhosis: A meta-analysis. _Journal of Hepatology_. 2021. Vol. 76, núm. 3, pàgs. 588-599. [consulta: 10 de gener de 2026]. ISSN: 0168-8278. [Disponible a: https://hdl.handle.net/2445/188881]